Multiscale Analysis and Validation of Effective Drug Combinations Targeting Driver KRAS Mutations in Non-Small Cell Lung Cancer

Pharmacogenomics is a rapidly growing field with the goal of providing personalized care to every patient. Previously, we developed the Computational Analysis of Novel Drug Opportunities (CANDO) platform for multiscale therapeutic discovery to screen optimal compounds for any indication/disease by p...

Descripción completa

Detalles Bibliográficos
Autores principales: Bruggemann, Liana, Falls, Zackary, Mangione, William, Schwartz, Stanley A., Battaglia, Sebastiano, Aalinkeel, Ravikumar, Mahajan, Supriya D., Samudrala, Ram
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9867122/
https://www.ncbi.nlm.nih.gov/pubmed/36674513
http://dx.doi.org/10.3390/ijms24020997

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9867122/
https://www.ncbi.nlm.nih.gov/pubmed/36674513
http://dx.doi.org/10.3390/ijms24020997

Ejemplares similares